CSIMarket
 
The Clorox Company  (CLX)
Other Ticker:  
 
 
Price: $156.6600 $-0.76 -0.483%
Day's High: $157.84 Week Perf: -3.48 %
Day's Low: $ 156.24 30 Day Perf: -7.04 %
Volume (M): 10 52 Wk High: $ 178.21
Volume (M$): $ 1,581 52 Wk Avg: $147.99
Open: $157.28 52 Wk Low: $120.50



 Market Capitalization (Millions $) 19,371
 Shares Outstanding (Millions) 124
 Employees 9,000
 Revenues (TTM) (Millions $) 7,171
 Net Income (TTM) (Millions $) 84
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 223

The Clorox Company
The Company was originally founded in Oakland, California in 1913 as the Electro-Alkaline Company. It was reincorporated as Clorox Chemical Corporation in 1922, as Clorox Chemical Co. in 1928 and as The Clorox Company (an Ohio corporation) in 1957, when the business was acquired by The Procter & Gamble Company. The Company's business operations, represented by the aggregate of its Household Products ' North America, Specialty Products, and Household Products ' Latin America/Other, include the production and marketing of consumer products sold primarily through grocery, mass merchandise, club and other retail stores.


   Company Address: 1221 Broadway Oakland 94612 CA
   Company Phone Number: 271-7000   Stock Exchange / Ticker: NYSE CLX
   CLX is expected to report next financial results on August 09, 2023. Next quarterly dividend pay out on August 14, 2023.


Customers Net Income grew by CLX's Customers Net Profit Margin grew to

205.3 %

9.49 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CHD        0.31% 
ECL        2.53% 
HWKN        8.16% 
PG        0.03% 
SEE   -2.77%    
WDFC   -0.05%    
• View Complete Report
   



Rex American Resources Corporation

The markets are very impressed with the rise in revenue at REX in the fiscal three months ending April 30 2023

As a journalist covering financial results, I have analyzed the first quarter of 2023 earnings season for Rex American Resources Corporation. The company has achieved break-even of $0.00 per share, which is the same as the previous year. However, it is a significant improvement from the previous reporting period where it had earnings of $0.46 per share.
In terms of revenue, the company has shown growth of 9.518% to $212.71 million from $194.23 million in the corresponding reporting period a year earlier. Moreover, there has been a sequential growth of 6.268% from $200.17 million. This indicates that Rex American Resources Corporation has been successful in driving revenue growth, which is a positive sign for investors.

Csw Industrials Inc

Strong Eps Underlines Double Digits revenue advance at in the fiscal period closing March 31 2023

Investors in the stock market are in for exciting news as CSW Industrials Inc releases its financial report for the period ending March 31, 2023. The chemical manufacturing company experienced impressive growth as profit per share soared by 38.71% to $1.75 per share, followed by a revenue boost of 12.918% to $195.69 million compared to the previous year. This financial milestone shows that CSW Industrials Inc is a company on the rise, with earnings per share soaring by 73.11% from $1.01 per share, while revenue advanced by 14.373% from $171.09 million.
CSW Industrials Inc also reported earnings of $27.122 million in the fiscal period closing March 31, 2023, representing a 35.75% increase from net earnings of $19.979 million reported in the fiscal period closing March 31, 2022, a year ago. There was a significant improvement in its profit margins, with net margin rising to 13.86% in the said period, and operating margin edging up to 20.32%. Operating earnings improved by 28.83% to $39.764 million.

Originclear Inc

An Outstanding 62.579%, rise in revenue at OCLN all along the financial interval ending March 31 2023

It's been an exciting time in the stock market lately, with some fantastic news coming from Originclear Inc. The latest financial report shows that for the fiscal span closing March 31, 2023, the company reached a break-even of $0.00 per share, which is a significant improvement from the previous year's negative $0.01 per share, and even a slight improvement from the $0.02 per share in the previous quarter.
But that's not all - Originclear Inc also saw an impressive 62.579% rise in revenue, totaling $2.01 million, compared to just $1.23 million a year ago. And while it's worth noting that there was a 23.081% drop in sequential revenue from $2.61 million, there's no doubt that Originclear Inc is on an upward trajectory.

Asp Isotopes Inc

The arising entity from the Chemical Manufacturing sector the Asp Isotopes Inc issued the fiscal first quarter of 2023, earnings

As a journalist, I have been following the financial results of the ASPI and it appears that stockholders were not expecting any significant changes in the business during the January to March quarter of 2023. However, investors are keeping a close eye on the company's operating loss which came in at $-3.724824 million during the same period.
It is worth noting that in the fiscal first quarter of 2023, Asp Isotopes Inc reported a net shortfall of $-3.615 million as opposed to a break-even in the same quarter of the previous year. This indicates that the company has experienced a significant decline in its financial performance over the past year, which is cause for concern among investors.

Artemis Therapeutics Inc

Artemis Therapeutics Inc released Revenue of $0.173 million, in the most recent fiscal period

The Chemical Manufacturing company recently announced its revenue for the most recent fiscal period, which amounted to $0.173 million. This news is significant for the company as it showcases the financial health of the company and provides insights into its recent performance.
However, it is important to note that another company, Artemis Therapeutics Inc, did not report a positive financial outcome for the same reporting season. Instead of recording a zero gain, the company showed a net deficit of $-0.249 million. This news suggests that Artemis Therapeutics Inc is experiencing financial difficulties that are affecting its bottom lineInvestors and analysts are likely to closely monitor Artemis Therapeutics Inc in the coming months to see if the company can bounce back from its losses and improve its financial outlook. The company is expected to report its next financial earnings on May 22, 2023, which will provide updates on its progress.
While both companies operate in different industries and have distinct business models, the news of their respective financial outcomes serves as a reminder of the importance of financial reporting. Companies that publicly disclose their earnings enable investors and stakeholders to evaluate their financial performance and make informed decisions about whether to invest in the company.
In conclusion, the news of Chemical Manufacturing company's revenue and Artemis Therapeutics Inc's net deficit offer important insights into the financial health of these companies and can help investors and stakeholders make informed decisions. As we continue to navigate the uncertain economic climate, monitoring financial reports remains a crucial task for all market participants.






 

The Clorox's Segments
 
Household
 Segment     of total Revenue
International
 Segment     of total Revenue
Cleaning
 Segment     of total Revenue
Lifestyle
 Segment     of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
The Clorox announced annual revenue outlook on

Earnings Outlook
The Clorox Company issued annual earnings guidance on

 
Geographic Revenue Dispersion
United States
International




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071